rs137852301
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000032.5(ALAS2):c.495C>A(p.Phe165Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 23)
Consequence
ALAS2
NM_000032.5 missense
NM_000032.5 missense
Scores
10
6
1
Clinical Significance
Conservation
PhyloP100: 4.27
Genes affected
ALAS2 (HGNC:397): (5'-aminolevulinate synthase 2) The product of this gene specifies an erythroid-specific mitochondrially located enzyme. The encoded protein catalyzes the first step in the heme biosynthetic pathway. Defects in this gene cause X-linked pyridoxine-responsive sideroblastic anemia. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.972
PP5
Variant X-55021195-G-T is Pathogenic according to our data. Variant chrX-55021195-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 10470.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALAS2 | NM_000032.5 | c.495C>A | p.Phe165Leu | missense_variant | 5/11 | ENST00000650242.1 | NP_000023.2 | |
ALAS2 | NM_001037968.4 | c.456C>A | p.Phe152Leu | missense_variant | 5/11 | NP_001033057.1 | ||
ALAS2 | NM_001037967.4 | c.384C>A | p.Phe128Leu | missense_variant | 4/10 | NP_001033056.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALAS2 | ENST00000650242.1 | c.495C>A | p.Phe165Leu | missense_variant | 5/11 | NM_000032.5 | ENSP00000497236 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 08, 2021 | Experimental studies have shown that this variant affects ALAS2 protein function (PMID: 7949148). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALAS2 protein function. This variant has been observed in individual(s) with X-linked sideroblastic anemia (PMID: 7949148). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10470). This variant is not present in population databases (ExAC no frequency). This sequence change replaces phenylalanine with leucine at codon 165 of the ALAS2 protein (p.Phe165Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. - |
X-linked sideroblastic anemia 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 21, 2005 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D;D;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;M;M;.;.;.
MutationTaster
Benign
A;A;A
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;.;D;D;.;.
REVEL
Pathogenic
Sift
Uncertain
D;.;D;D;.;.
Sift4G
Pathogenic
D;.;D;D;.;.
Polyphen
0.99
.;D;D;.;.;.
Vest4
MutPred
0.87
.;Loss of methylation at K166 (P = 0.0384);Loss of methylation at K166 (P = 0.0384);.;.;.;
MVP
MPC
1.5
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at